Breast Implant Class Action: Biocell Recall Claims and Eligibility

Breast Implant Class Action: Your Rights After the Biocell Recall

A breast implant class action or individual lawsuit may provide compensation to people harmed by defective implants, especially those who received Allergan’s recalled Biocell textured implants, which have been linked to a rare lymphoma. These cases let large numbers of patients pursue a manufacturer that allegedly failed to warn about serious risks.

Breast Implant Class Action Basics:

• Main product at issue: Allergan Biocell textured implants, recalled worldwide in 2019
• Primary health concern: BIA-ALCL (breast implant-associated anaplastic large cell lymphoma), a rare immune-system cancer
• Who may qualify: People who received certain Allergan textured products, generally implanted from the late 1990s through 2019
• Cost: Attorneys typically work on contingency, with no upfront fees
• Where cases stand: A federal MDL in New Jersey and a certified class action in Canada
• Damages sought: Medical monitoring, removal and replacement surgery, pain and suffering

The FDA’s 2019 analysis found that BIA-ALCL risk with Allergan Biocell textured implants was about six times higher than with textured implants from other makers. Of 573 BIA-ALCL cases reported worldwide at that time, 481 involved Allergan implants, including 33 deaths.

These cases aim to hold the manufacturer responsible for allegedly putting sales ahead of patient safety. Many patients say they would have chosen differently had they been told about the cancer risk.

Helping people find legal resources has shown how breast implant class action cases can deliver both accountability and financial relief to those hurt by defective devices. Knowing your rights matters when a recalled product affects your health.

Related breast implant class action topics:

• breast cancer class action lawsuit
• breast implant recall 2023

Textured Implants and BIA-ALCL: What the Cancer Risk Means

If you have textured implants, understanding BIA-ALCL will help you make informed decisions about your health.

BIA-ALCL means breast implant-associated anaplastic large cell lymphoma. It is a rare cancer of the immune system, a type of non-Hodgkin lymphoma, and it is not breast cancer. It usually forms in the scar capsule surrounding the implant, and the World Health Organization classifies it as a T-cell lymphoma. Its strong association with textured implants, particularly Allergan’s Biocell line, is what drives this litigation.

Warning Signs and Other Implant Risks

BIA-ALCL symptoms can appear years after surgery, so knowing the signs is important.

Ongoing swelling is frequently the first sign, such as one breast suddenly becoming larger or persistent swelling around an implant. Pain near the implant that does not resolve is another.

Other signs include lumps in the breast or armpit, a fluid buildup around the implant (seroma), redness or warmth and changes in breast shape or size. See a doctor promptly if you notice any of these; early detection matters.

Separately, many patients report breast implant illness (BII), sometimes discussed as ASIA syndrome. Research is ongoing, but many describe similar symptoms, including fatigue, joint and muscle pain, brain fog, hair loss, rashes and, in some cases, autoimmune conditions such as lupus or rheumatoid arthritis.

Implants can also rupture early, leading to more surgery and complications. Staying informed helps you advocate for the care you need.

The FDA’s information on BIA-ALCL symptoms is a reliable source of medical guidance.

Textured vs. Smooth Implants

Surface texture is central to the breast implant class action claims against Allergan.

Biocell implants have an aggressive, macro-textured surface with a rough, sandpaper-like feel. The texture was meant to help the implant grip surrounding tissue and reduce rotation or capsular contracture.

Researchers suspect that rough surface may also cause chronic irritation and inflammation, and possibly harbor bacteria, conditions thought to contribute to BIA-ALCL. Regulators found Allergan’s textured products carried roughly six times the BIA-ALCL risk of other textured implants.

Smooth implants have a slick surface that moves more naturally within the breast. No implant is risk-free, but smooth implants have not been associated with BIA-ALCL at anything like the same rate.

Knowing the difference helps you talk with your doctor. If textured implants have affected your health, legal help may be available.

The Allergan Biocell Recall and the Lawsuits That Followed

In July 2019, at the FDA’s request, Allergan issued a worldwide recall of its Biocell textured breast implants and tissue expanders. The FDA classified it as a Class I recall, its most serious category, meaning use of the product could cause serious injury or death.

Earlier in 2019, Health Canada had suspended Allergan’s Biocell licenses over the same cancer concerns, as evidence of elevated BIA-ALCL risk mounted.

Health Canada’s recall notice lists the affected products in detail.

What the Lawsuits Allege and Where They Stand

Claims in the breast implant class action litigation argue that Allergan knew or should have known about the risk but did not adequately warn patients or surgeons. Plaintiffs allege the company:

• Did not adequately warn about BIA-ALCL.
• Was negligent in designing and manufacturing the implants without disclosing long-term safety issues.
• Relied on misleading marketing that overstated benefits.
• Minimized known risks and failed to monitor safety after launch.

Plaintiffs say this left patients facing a higher cancer risk than they were told.

Recalled Biocell products included textured Natrelle saline implants, Natrelle 410 Truform silicone implants, Natrelle silicone implants with Biocell round texturing, textured Natrelle Inspira Truform 1 and 2 implants and several Biocell textured tissue expanders.

U.S. federal cases were consolidated in December 2019 into a multidistrict litigation (MDL) in the District of New Jersey, with more than 1,200 cases reported pending as of September 2024. Rulings on preemption have narrowed some claims, so case status and options vary.

In Canada, a breast implant class action against Allergan was certified, allowing people in British Columbia, Ontario, Quebec and other provinces to pursue claims together, a significant step for affected patients.

Both proceedings seek accountability from Allergan and safer practices going forward.

For the latest on resolution efforts, see our page on the Allergan textured implant lawsuit settlement.

How a Breast Implant Class Action Works and Who Qualifies

A breast implant class action lets people harmed by the same product pursue a large company together, which can make legal action more practical than going it alone.

Shared costs give access to strong representation, collective claims add leverage, and people whose individual losses might not justify a separate lawsuit still have a path to recovery. The approach is well suited to defective device cases like the Biocell recall.

Who Can Join a Breast Implant Class Action

You may qualify if you received recalled Allergan Biocell products, such as textured saline implants, Natrelle 410 implants or Biocell tissue expanders, generally between May 1999 and May 2019. Exact criteria depend on the court and jurisdiction.

You may not need to be sick to have a claim. Some claims focus on the cost of monitoring and removing recalled devices because of the increased cancer risk, whether or not you have symptoms.

Family members may have claims too. If a loved one suffered serious complications or died from BIA-ALCL, relatives may pursue loss of consortium or wrongful death claims.

Joining costs nothing upfront. Attorneys generally work on contingency and are paid a percentage of any recovery, so you owe no legal fee if the case does not succeed.

Staying In vs. Opting Out

If you fall within a certified class, you are included automatically, bound by the outcome and entitled to a share of any recovery.

You can opt out to file your own lawsuit, which may make sense if your losses are much larger than a class settlement would likely pay or you want more control. Opting out means taking on the costs and risk of proving your own case.

Deadlines are strict. The opt-out deadline in the Canadian Allergan class action was June 30, 2025; people who did not opt out by then remain class members.

The official Canadian class action website posts the court notices and forms.

Next Steps if You Have Biocell Implants

If you may have Allergan Biocell implants, start by confirming exactly which implants you have, since many patients are unsure.

Ways to identify your implants:

• Your implant card: usually lists the manufacturer, surface type and model or serial number.
• Your operative records: hospitals and surgical centers keep detailed device records.
• Your surgeon’s office: often the quickest way to get this information.

Steps to Take if You Are Affected

Whether or not you have symptoms, these steps protect your health and any claim:

1. See a doctor promptly. Choose a provider familiar with implant-related conditions.
2. Get any symptoms properly evaluated. Make sure findings and test results are documented.
3. Keep organized records. Save medical records, visit notes, test results, treatment details and expenses, including missed work.

What compensation can a breast implant class action provide?

Recovery is meant to cover the costs and harm caused by allegedly defective implants and may include:

• Ongoing medical monitoring.
• Diagnostic tests such as imaging or biopsies.
• Removal surgery (explantation).
• Replacement implants.
• Lost income if symptoms kept you from working.
• Pain, suffering and emotional distress, including the anxiety of living with the risk.

The aim is to keep you from bearing the cost of a manufacturer’s alleged failures. Learn more on our active lawsuits page.

Breast Implant Lawsuit FAQs

Here are answers to common questions about a breast implant class action.

Does it cost anything to join a breast implant class action?

Usually not. Attorneys handling breast implant class action claims typically use a contingency fee, taking the financial risk themselves and collecting a percentage only if money is recovered.

Can I have a claim without BIA-ALCL symptoms?

Possibly. Depending on the jurisdiction, people with recalled Biocell implants may seek certain damages even without symptoms, because they live with a device linked to cancer.

• Monitoring: the cost of screenings to catch BIA-ALCL early.
• Explantation: the cost of removing and possibly replacing the implants.
• Emotional harm: anxiety about the increased risk, recognized in some jurisdictions.

The FDA has published guidance for patients and providers, including its position that implants generally need not be removed in patients without symptoms.

How long will these cases take?

Complex device litigation usually takes years. It involves extensive discovery and expert testimony; an MDL coordinates similar cases, and bellwether trials can shape settlement talks. A global resolution, if reached, can compensate eligible people faster than individual trials.

Protecting Your Health and Your Rights

Dealing with a recalled implant can be stressful, but you are not alone. The Allergan Biocell recall is a major device safety issue, and the elevated BIA-ALCL risk affects many patients.

Regulators found these textured implants carried about six times the BIA-ALCL risk of comparable products, and many patients say they were never properly warned. Legal options exist through class actions and individual claims to seek compensation and accountability.

This guide covered BIA-ALCL, textured implant risks, the recall and how class actions and eligibility work.

If you have Biocell or other textured implants, stay informed, get prompt medical advice for any symptoms and consider a legal review of your options.

Legal Lawsuit can connect you with independent attorneys experienced in breast implant class action and device injury cases for a free, confidential review.

A consultation carries no obligation, and acting early helps protect deadlines that could affect your claim.

Take the first step toward answers and accountability today.

See whether you may qualify for a claim.